By Daniel R. Matlis, President
What Can Pharma CIOs do to Enable Innovation
What is the role of a CIO in a Pharma / Life-Science company? Traditionally, the role of the CIO has been to manage the IT portfolio, implement systems, manage infrastructure and control IT costs to support the business.
With the unprecedented rate of shift the industry is experiencing, CIO’s can no longer simply be tasked with managing portfolios and budgets.
This was evident at the 2015 CIO Innovation Summit in Kyoto, Japan on October 20th.
There, Executives from leading organizations across the Life-Sciences ecosystem in Asia converged at the Ritz Carlton in Kyoto to learn about industry trends and share success stories and current best practices (cBPs).
Key themes at the event included innovation, transformation, collaboration and connectivity. The event was hosted by BIOVIA – Dassault Systemes and brought together top executives from:
- Astellas Pharma
- Daichi Sankyo
- Everlight Chemical
- Genesis Genetics Asia
- IPCA Laboratories
- Samsung Biologics
- Shionogi &Co
- Sumitomo Danippon
- Takeda Pharmaceuticals
- Mitsui Chemicals
- WuXi Apptech
Max Carnecchia, BIOVIA’s CEO, set the tone for the event in his opening remarks. His message: “By transforming the pharmaceutical industry through innovation, collaboration and connectivity, we can streamline end-to-end manufacturing, enhance quality and improve compliance in today’s challenging regulatory and risk environment.”
To learn more about illuminating dark data, please click here for a PDF copy of the entire Event Brief.